Quick Answer
Jaguar Health, Inc. reported Stockholders Equity of $17.20 million for the year ending 2020.
- Jaguar Health, Inc. showed an increase of +61.2% in Stockholders Equity from 2019 to 2020.
- This data is from Jaguar Health, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2021.
- XBRL data for this metric is available from 2013 to 2020 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: -$11.85 million | Q2 2015: $11.11 million | Q3 2015: $8.37 million | Q1 2016: $4.65 million | Q2 2016: $1.57 million | Q3 2016: -$273.0 thousand | Q1 2017: -$6.19 million | Q2 2017: -$6.27 million | Q3 2017: $31.81 million | Q1 2018: $21.01 million | Q2 2018: $14.02 million | Q3 2018: $10.32 million | Q1 2019: $6.79 million | Q2 2019: -$1.65 million | Q3 2019: $11.38 million | Q4 2019: $10.67 million | Q1 2020: $6.23 million | Q2 2020: $1.54 million | Q3 2020: $7.81 million | Q4 2020: $17.20 million | Q1 2021: $31.89 million | Q2 2021: $31.79 million | Q3 2021: $21.55 million.
- Over the full 8 years of available data (2013 to 2020), Jaguar Health, Inc.'s Stockholders Equity has grown by 4,055.8%.
- Historical annual values: Fiscal year 2020: $17.20 million | Fiscal year 2019: $10.67 million | Fiscal year 2018: $5.38 million | Fiscal year 2017: $17.26 million | Fiscal year 2016: -$2.45 million | Fiscal year 2015: $4.40 million | Fiscal year 2014: -$8.24 million | Fiscal year 2013: -$434.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: